Tristel PLC Half Yearly Report -4-
February 25 2015 - 2:00AM
UK Regulatory
The financial information relating to the year ended 30 June
2014 does not constitute full financial statements within the
meaning of Section 434 of the Companies Act 2006. This information
is based on the Group's statutory accounts for that period. The
statutory accounts were prepared in accordance with International
Financial Reporting Standards ("IFRS") and received an unqualified
audit report and did not contain statements under Section 498(2) or
(3) of the Companies Act 2006. These financial statements have been
filed with the Registrar of Companies.
3 SEGMENTAL ANALYSIS
The Board considers the Group's revenue lines to be split into
three operating segments, which span the different Group entities.
The operating segments consider the nature of the product sold, the
nature of production, the class of customer and the method of
distribution. The Group's operating segments are identified from
the information which is reported to the chief operating decision
maker.
The first segment concerns the manufacture, development and sale
of infection control and hygiene products which incorporate the
Company's chlorine dioxide chemistry, and are used primarily for
infection control in hospitals ("Human Health"). This segment
generates approximately 86% of Group revenues.
The second segment, which constitutes 5% of the business
activity, relates to manufacture and sale of disinfection and
cleaning products, principally into veterinary and animal welfare
sectors ("Animal Health").
The third segment addresses the pharmaceutical and personal care
manufacturing industries ("Contamination Control"). This activity
has generated 9% of the Group's revenue for the period.
The operation is monitored and measured on the basis of the key
performance indicators of each segment, these being revenue and
gross profit; strategic decisions are made on the basis of revenue
and gross profit generating from each segment.
The Group's centrally incurred administrative expenses,
operating income, assets and liabilities are not attributable to
individual segments.
3 SEGMENTAL ANALYSIS - continued
6 months ended 6 months ended Year ended
31 December 2014 31 December 2013 30 June 2014
(unaudited) (unaudited) (audited)
Human Animal Cont'n Total Human Animal Cont'n Total Human Animal Cont'n Total
Health Health Control Health Health Control Health Health Control
GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000
Revenue 6,322 397 693 7,412 5,536 327 579 6,442 11,518 762 1,190 13,470
Cost
of
material (1,798) (153) (350) (2,301) (1,549) (121) (282) (1,952) (3,216) (255) (595) (4,066)
------------ --------------- -------------- ----------- -------------- -------------- ---------- ---------- ------------ ------------ --------- ---------
Gross
profit 4,524 244 343 5,111 3,987 206 297 4,490 8,302 507 595 9,404
============ =============== ============== ============== ============== ========== ============ ============ =========
Centrally incurred income
and expenditure not
attributable to individual
segments:-
Dep'n & amort'n of
non- financial assets (422) (449) (885)
Other administrative
expenses (3,600) (3,296) (6,685)
Share based payments (67) (22) (15)
----------- --------- ---------
Segment operating profit 1,022 723 1,819
----------- --------- ---------
Segment operating profit
can be reconciled to Group
profit before tax as follows:-
Segment operating profit 1,022 723 1,819
Results from equity
accounted associate 8 5 8
Finance income 7 2 6
Finance costs (4) (6) (10)
Group profit 1,033 724 1,823
=========== ========= =========
The Group's revenues from external customers are divided into the following
geographical areas:
6 months ended 6 months ended Year ended
31 December 2014 31 December 2013 30 June 2014
(unaudited) (unaudited) (audited)
Human Animal Cont'n Total Human Animal Cont'n Total Human Animal Cont'n Total
healthcare healthcare control healthcare healthcare control healthcare healthcare Control
GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000
United
Kingdom 4,230 258 518 5,006 3,809 231 451 4,491 7,439 550 950 8,939
Rest
of the
World 2,092 139 175 2,406 1,727 96 128 1,951 4,079 212 240 4,531
------------ --------------- -------------- ----------- -------------- -------------- ---------- ---------- ------------ ------------ --------- ---------
Group
Revenues 6,322 397 693 7,412 5,536 327 579 6,442 11,518 762 1,190 13,470
============ =============== ============== =========== ============== ============== ========== ========== ============ ============ ========= =========
4 EARNINGS PER SHARE
The calculations of earnings per share are based on the
following profits and number of shares:
6 months ended 6 months Year ended
31 December ended 30 June 2014
2014 31 December
2013
(unaudited) (unaudited) (audited)
Retained profit for the
period attributable to equity
holders of the parent 773 413 1,298
================ ============== ===============
Shares '000 Shares '000 Shares '000
Number Number Number
Weighted average number
of ordinary shares for the
purpose of basic earnings
per share 40,523 39,985 39,989
Share options 2,127 - -
Weighted average number
of ordinary shares for the
purpose of diluted earnings
per share 42,650 39,985 39,989
================ ============== ===============
Earnings per ordinary share
Basic (pence) 1.91 1.03 3.25
Tristel (LSE:TSTL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tristel (LSE:TSTL)
Historical Stock Chart
From Apr 2023 to Apr 2024
